Various aspects of synergism between endotoxin and MDPs.
Parant
M
M
Laboratory of Experimental Immunopharmacology, Institut Biomédical des Cordeliers, Paris, France.
Chedid
L
L
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D004357:Drug Synergism; D004731:Endotoxins / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced; D006168:Guinea Pigs; D007202:Indicators and Reagents; D007710:Klebsiella Infections / Q000276:immunology; D007711:Klebsiella pneumoniae; D008070:Lipopolysaccharides / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D004731:Endotoxins; D007202:Indicators and Reagents; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D000119:Acetylmuramyl-Alanyl-Isoglutamine